| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Qiong Sha, Zach Madaj, Sarah Keaton, Martha L Escobar Galvis, LeAnn Smart, Stanislaw Krzyzanowski, Asgerally T Fazleabas, Richard Leach, Teodor T Postolache, Eric D Achtyes, Lena Brundi. Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy. Translational psychiatry. vol 12. issue 1. 2022-01-26. PMID:35078975. |
we analyzed plasma il-1β, il-2, -6, -8, -10, tnf, kynurenine, tryptophan, serotonin, kynurenic- quinolinic- and picolinic acids and used mixed-effects models to assess the association between biomarkers and depression severity. |
2022-01-26 |
2023-08-13 |
Not clear |
| Hussein Kadhem Al-Hakeim, Hadi Hasan Hadi, Ghoufran Akeel Jawad, Michael Mae. Intersections between Copper, β-Arrestin-1, Calcium, FBXW7, CD17, Insulin Resistance and Atherogenicity Mediate Depression and Anxiety Due to Type 2 Diabetes Mellitus: A Nomothetic Network Approach. Journal of personalized medicine. vol 12. issue 1. 2022-01-21. PMID:35055338. |
the present study delineated the effects of serum levels of copper, zinc, β-arrestin-1, fbxw7, lactosylceramide (laccer), serotonin, calcium, magnesium on severity of depression and anxiety in 58 men with t2dm and 30 healthy male controls beyond the effects of insulin resistance (ir) and atherogenicity. |
2022-01-21 |
2023-08-13 |
Not clear |
| Chieh-Hsin Lin, Shi-Heng Wang, Hsien-Yuan Lan. Effects of sodium benzoate, a D-amino acid oxidase inhibitor, on perceived stress and cognitive function among patients with late-life depression: A randomized, double-blind, sertraline- and placebo-controlled trial. The international journal of neuropsychopharmacology. 2022-01-13. PMID:35023557. |
this study aims to compare sodium benzoate (a d-amino acid oxidase [daao] inhibitor and an indirect nmdar enhancer), sertraline (a selective serotonin reuptake inhibitor), and placebo in the treatment of late-life depression. |
2022-01-13 |
2023-08-13 |
Not clear |
| Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk, Agnieszka A Kaczo. Overcoming Depression with 5-HT International journal of molecular sciences. vol 23. issue 1. 2022-01-11. PMID:35008436. |
overcoming depression with 5-ht depression is a multifactorial disorder that affects millions of people worldwide, and none of the currently available therapeutics can completely cure it. |
2022-01-11 |
2023-08-13 |
Not clear |
| Kan Gao, Aitak Farzi, Xueqin Ke, Yunxia Yu, Cailin Chen, Su Chen, Tengfei Yu, Haifeng Wang, Yanjun L. Oral administration of Food & function. 2022-01-10. PMID:35006225. |
oral administration of depression is a mood disorder with a high prevalence rate globally, which is associated with abnormalities in 5-hydroxytryptamine (5-ht) metabolism. |
2022-01-10 |
2023-08-13 |
Not clear |
| Kan Gao, Aitak Farzi, Xueqin Ke, Yunxia Yu, Cailin Chen, Su Chen, Tengfei Yu, Haifeng Wang, Yanjun L. Oral administration of Food & function. 2022-01-10. PMID:35006225. |
emerging evidence suggests that certain probiotics that modulate 5-ht metabolism confer beneficial effects on depression. |
2022-01-10 |
2023-08-13 |
Not clear |
| Moitreyee Chattopadhyay, Souvik Basak, Atish Barua, Malaya Gupta, Dibyajyoti Das, Tanushree Karmakar, Gautam Kumar Bagch. Neuropharmacological Alterations by a Rice Contaminant Stenotrophomonas maltophilia: a Detailed Bio-molecular and Mechanistic Landscape. Applied biochemistry and biotechnology. 2022-01-10. PMID:35006552. |
throughout the study, both acute and chronic exposure of the cell lysate showed a decrease in the locomotor activity and a time-dependent increase of the depression (p < 0.001-0.0001, two-way anova), supported by bioamine (dopamine, noradrenaline, adrenaline, serotonin, and gaba) depletion in rodents' brain possibly due to ufa-amino acid decarboxylase interaction favoring bioamine depletion as revealed by our study. |
2022-01-10 |
2023-08-13 |
human |
| Naili Wei, Ce Li, Yulian Zhu, Peiqi Zheng, Ruiping Hu, Jian Che. Fluoxetine regulates the neuronal differentiation of neural stem cells transplanted into rat brains after stroke by increasing the 5HT level. Neuroscience letters. 2022-01-10. PMID:35007690. |
fluoxetine, a 5-ht uptake inhibitor, has been adopted for the treatment of post-stroke depression in recent years. |
2022-01-10 |
2023-08-13 |
rat |
| Martin J Lan, Francesca Zanderigo, Spiro P Pantazatos, M Elizabeth Sublette, Jeffrey Miller, R Todd Ogden, J John Man. Serotonin 1A Receptor Binding of [ 11C]CUMI-101 in Bipolar Depression Quantified using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response. The international journal of neuropsychopharmacology. 2022-01-07. PMID:34996114. |
serotonin 1a receptor binding of [ 11c]cumi-101 in bipolar depression quantified using positron emission tomography: relationship to psychopathology and antidepressant response. |
2022-01-07 |
2023-08-13 |
Not clear |
| Maggie A Stanislawski, Christopher E Stamper, Kelly A Stearns-Yoder, Andrew J Hoisington, Diana P Brostow, Jeri E Forster, Teodor T Postolache, Christopher A Lowry, Lisa A Brenne. Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study. Brain, behavior, & immunity - health. vol 18. 2022-01-06. PMID:34988495. |
we observed significant associations between the gut microbiota composition and gastroenteritis, peripheral vascular disease (pvd), bipolar disorders, symptoms of severe depression based on the beck depression inventory, stimulant and opioid use disorders, beta-blockers, serotonin and norepinephrine reuptake inhibitor antidepressants, diabetes medications, and proton pump inhibitors. |
2022-01-06 |
2023-08-13 |
Not clear |
| Tayebeh Noori, Antoni Sureda, Eduardo Sobarzo-Sánchez, Samira Shirooi. The Role of Natural Products in Treatment of Depressive Disorder. Current neuropharmacology. 2022-01-04. PMID:34979889. |
common treatments for depression are selective serotonin reuptake inhibitors, tricyclic antidepressants, and monoamine oxidase inhibitors, but these drugs have several side effects such as anxiety, diarrhea, constipation, weight loss, and sexual dysfunctions. |
2022-01-04 |
2023-08-13 |
Not clear |
| Archana Mishra, Sudhir Chandra Sarangi, Rituparna Maiti, Mamta Sood, K H Reet. Efficacy and safety of adjunctive serotonin-dopamine activity modulators in major depression: A meta-analysis of randomized controlled trials. Journal of clinical pharmacology. 2021-12-30. PMID:34967946. |
this meta-analysis evaluated the effect of augmentation with serotonin dopamine activity modulator (sdam) drugs in patients with major depression. |
2021-12-30 |
2023-08-13 |
Not clear |
| Carolina Ramos de Mendonça, Raul Manhães-de-Castro, Bárbara Juacy Rodrigues Costa de Santana, Luana Olegário da Silva, Ana Elisa Toscano, Omar Guzmán-Quevedo, Lígia Cristina Monteiro Galind. Effects of flavonols on emotional behavior and compounds of the serotonergic system: A preclinical systematic review. European journal of pharmacology. 2021-12-26. PMID:34954234. |
an imbalance of 5-ht in the brain can modulate emotional behavior such as depression and anxiety. |
2021-12-26 |
2023-08-13 |
Not clear |
| Daniel Richter, Jeyanthan Charles James, Andreas Ebert, Aristeidis H Katsanos, Lisa Mazul-Wach, Quirin Ruland, Ralf Gold, Georg Juckel, Christos Krogia. Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis. Journal of clinical medicine. vol 10. issue 24. 2021-12-24. PMID:34945207. |
selective serotonin reuptake inhibitors for the prevention of post-stroke depression: a systematic review and meta-analysis. |
2021-12-24 |
2023-08-13 |
human |
| Daniel Richter, Jeyanthan Charles James, Andreas Ebert, Aristeidis H Katsanos, Lisa Mazul-Wach, Quirin Ruland, Ralf Gold, Georg Juckel, Christos Krogia. Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis. Journal of clinical medicine. vol 10. issue 24. 2021-12-24. PMID:34945207. |
there are controversial data on the efficacy and safety profile of selective serotonin reuptake inhibitors (ssris) to prevent post-stroke depression (psd). |
2021-12-24 |
2023-08-13 |
human |
| Sugandha Gupta, Mengya Wang, Yoshiaki Azuma, Nancy A Mum. Regulation of Serotonin 1A Receptor SUMOylation by SENP2 and PIASxα. International journal of molecular sciences. vol 22. issue 24. 2021-12-24. PMID:34947973. |
serotonin 1a receptors (5-ht1ars) are implicated in the control of mood, cognition, and memory and in various neuropsychiatric disorders such as depression and anxiety. |
2021-12-24 |
2023-08-13 |
rat |
| Kiki Reski Rahmadani Bakri, Andi Nilawati Usman, Saidah Syamsuddin, Irfan Idris, Erlyn Limo. The effectiveness of gentle prenatal yoga on the recovery of depression level in pregnant women aged. Gaceta sanitaria. vol 35 Suppl 2. 2021-12-21. PMID:34929840. |
this study aimed to analyze the effectiveness of gentle prenatal yoga toward depression and abnormal serotonin hormone levels in pregnant women aged <20 and >35 years old. |
2021-12-21 |
2023-08-13 |
Not clear |
| Mario Altamura, Salvatore Iuso, Giovanna D'Andrea, Francesca D'Urso, Carla Piccininni, Eleonora Angelini, Francesco Sessa, Maurizio Margaglione, Caterina Padulo, Beth Fairfield, Annamaria Petito, Antonello Bellom. Maladaptive Coping Strategies and Neuroticism Mediate the Relationship Between 5HTT-LPR Polymorphisms and Symptoms of Anxiety in Elite Athletes. Clinical neuropsychiatry. vol 16. issue 1. 2021-12-15. PMID:34908940. |
the aim of this study was to examine whether neuroticism and maladaptive coping strategies mediate the association between the serotonin transporter gene-linked polymorphic region (5htt-lpr) and symptoms of anxiety and depression in elite athletes who experience high levels of competitive stress. |
2021-12-15 |
2023-08-13 |
Not clear |
| Bai Chuang Shyu, Alan Bh He, Ying H Yu, Andrew Chih Wei Huan. Tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain. Molecular pain. vol 17. 2021-12-14. PMID:34903115. |
tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain. |
2021-12-14 |
2023-08-13 |
Not clear |
| Bai Chuang Shyu, Alan Bh He, Ying H Yu, Andrew Chih Wei Huan. Tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain. Molecular pain. vol 17. 2021-12-14. PMID:34903115. |
whether the typical pharmacological treatments for cpsp, which include antidepressants, selective serotonin reuptake inhibitors (ssris), and anticonvulsants, can treat comorbid anxiety and depression symptoms in addition to pain remains unclear? |
2021-12-14 |
2023-08-13 |
Not clear |